Table: Aska Pharmaceutical - 6-MTH group results

ASKA Pharmaceutical Holdings

04/11/2020 06:00

Nov 4 (Reuters)- 
             Aska Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             27.40               26.58            53.00    
                 (+3.1 pct)          (+13.2 pct)      (+0.9 pct)  
  Operating          1.95              746 mln            2.00    
                (+160.7 pct)         (-22.3 pct)      (+32.7 pct) 
  Recurring          1.95              869 mln            1.90    
                (+124.5 pct)         (-19.3 pct)      (+10.8 pct) 
  Net                1.55              577 mln            1.50    
                (+168.9 pct)         (-22.4 pct)     (+131.1 pct) 
  EPS             54.77 yen           20.42 yen        52.95 yen  
  Ann Div                             17.00 yen        14.00 yen  
  -Q2 div         7.00 yen            7.00 yen                    
  -Q4 div                             10.00 yen        7.00 yen   
  
  NOTE - Aska Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T